| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |